The Declaration

WPDD Initiators and Supporters

The Western Pacific Declaration on Diabetes and its associated Plan of Action have been developed through a process of consultation that extended over one year and culminated in a meeting held in Kuala Lumpur, Malaysia, in June 2000. The meeting finalized and endorsed the Declaration and the Plan of Action.

The Declaration was signed by the International Diabetes Federation Western Pacific Region (IDF/WPR), World Health Organization Regional Office for the Western Pacific (WHO/WPRO), the Secretariat of the Pacific Community (SPC), and the host Government Malaysia during a signing ceremony on 4 June 2000 in Kuala Lumpur. The Declaration was also supported by the following organizations, associations, governments, WHO collaborating centres, institutions and government hospitals who participated in this meeting.

Organizations
World Health Organization Headquarters
International Diabetes Foundation Headquarters

Diabetes associations
Diabetes Australia, Diabetes Division-Hong Kong Society for the Study of Endocrinology, Metabolism and Reproduction, Indonesian Diabetic Association, Japan Diabetes Association, Korean Diabetes Association, Macau Diabetes Association, Malaysian Diabetes Association, Diabetes New Zealand, Diabetic Association of Papua New Guinea, Diabetic Society of Singapore, Diabetes Association of Thailand , Diabetes Association of Tonga

WHO collaborating centres
Center of Epidemiology of Diabetes and Health Promotion for Control of Noncommunicable Disease; International Diabetes Institute, Caulfield, Australia; Center for Diabetes Treatment and Education, Kyoto National Hospital, Kyoto Japan

National Institutions
Australia - Australian Center for Diabetes Strategies, Prince of Wales Hospital, Sydney; China - Chinese Academy of Preventive Medicine; Beijing Korea - Seoul National University; Mongolia - National Medical University of Mongolia, Ulan Bator; Pakistan - The Aga Khan University, Karachi; Philippines - University of the Philippines, Manila

Government Hospitals
Samoa - Tupua Tamasese Meaole Hospital, Apia; Vietnam - Endocrinology Hospital, Hanoi

Also present as observers, were representatives of Abbot Laboratories, Aventis Farma, Bayer Diagnostics, Becton Dickinson & Company, Eli Lily, Johnson & Johnson, Lifescan Asia Pacific, Merck Sharp and Dohme, Novartis, Novo Nordisk, Project Hope, Roche Diagnostics, SmithKline Beecham and Servier.